- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 8, 2025 | 167.07M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $2.48B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $2.48B |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $50M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $10M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $30.5M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $46.9M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $529.8M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $520.8M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $4.43B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $4.43B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $321.3M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $385.8M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $5.13B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $5.22B |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 161.4M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $52.4M |
| Capex | Q1 2025 · Mar 31, 2024 | $18.4M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $30.6M |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | $490.9M |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | $577.3M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.18 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.18 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $110.5M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$27.2M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $14M |
| Revenue | Q1 2025 · Mar 31, 2024 | $408.5M |